The fact that the best-fitting model was quadratic rather than strictly linear is itself informative: it suggests that pushing the dose to 6.0 mg did not buy additional histologic benefit and may have shifted the tolerability balance, exactly the kind of nuance a dose-finding trial exists to surface
December 18, 2024: FDA Updates Ozempic Warning Label to Include Pulmonary Aspiration as Adverse Reaction The FDA updated the warning label for Ozempic, the GLP-1 drug used to treat diabetes and lose weight
Fragrance-free formula that leaves the skin clear, calm, and nourished after every use
One promising option is a modern version of an older technique
Zachariou V, Brunzell DH, Hawes J, Stedman DR, Bartfai T, Steiner RA, et al